SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QuestCor QSC

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Selfop who wrote (112)2/22/1999 1:47:00 AM
From: dwight martin  Read Replies (1) of 120
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934



CYPROS PHARMACEUTICAL CORPORATION
(Name of Issuer)

Common Stock
(Title of Class of Securities)

232808105
(CUSIP Number)

December 31, 1998
(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:

[x] Rule 13d-1(b)

[x] Rule 13d-1(c)

[x] Rule 13d-1(d)

*The remainder of this cover page shall be filled out
for a reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover
page shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).

CUSIP 232808105 SCHEDULE 13G Page 2 of 7

1 Name Of Reporting Person WENTWORTH, HAUSER & VIOLICH

IRS Identification No. Of Above Person

2 Check The Appropriate Box If A Member Of A Group (a) [ ]
N/A
(b) [ ]
3 SEC USE ONLY

4 Citizenship Or Place Of Organization

California, United States

5 Sole Voting Power
NUMBER OF
SHARES 957,705
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
6 Shared Voting Power

-0-

7 Sole Dispositive Power

957,705

8 Shared Dispositive Power

-0-

9 Aggregate Amount Beneficially Owned By Each Reporting Person

957,705

10 Check Box If The Aggregate Amount In Row (9) Excludes Certain
Shares*

11 Percent Of Class Represented By Amount In Row 9

6.1%

12 Type Of Reporting Person*

IA

CUSIP 232808105 SCHEDULE 13G Page 3 of 7

1 Name Of Reporting Person LAIRD NORTON TRUST COMPANY OF SEATTLE

IRS Identification No. Of Above Person

2 Check The Appropriate Box If A Member Of A Group (a) [ ]
N/A
(b) [ ]
3 SEC USE ONLY


4 Citizenship Or Place Of Organization

Washington, United States

5 Sole Voting Power
NUMBER OF
SHARES -0-
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
6 Shared Voting Power

957,705

7 Sole Dispositive Power

-0-

8 Shared Dispositive Power

-0-

9 Aggregate Amount Beneficially Owned By Each Reporting Person

957,705

10 Check Box If The Aggregate Amount In Row (9) Excludes Certain
Shares*

11 Percent Of Class Represented By Amount In Row 9

6.1%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext